Vimarsana
Biggest News Aggregation in the World

Page 8 - Therapeutic Development Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutic Development Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutic Development Programs Today - Breaking & Trending Today

StockNews.com Begins Coverage on Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) - Vimarsana News

StockNews.com Begins Coverage on Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB)

StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research report released on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Stock Performance Shares of NYSEAMERICAN:NAVB opened at $0.10 on Wednesday. The stock has a 50 day moving average of $0.15 and a 200 […]

Source: wkrb13.com
Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Price Performance NYSEAMERICAN:NAVB opened at $0.10 on Tuesday. Navidea Biopharmaceuticals has a 52 week low of $0.07 and a 52 […]

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Research Coverage Started at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research report released on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Price Performance NAVB stock opened at $0.10 on Tuesday. The company has a fifty day moving average price of $0.16 and a […]

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Coverage Initiated by Analysts at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research report report published on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Trading Up 7.8 % Shares of NAVB stock opened at $0.10 on Monday. The stock has a 50 day moving average […]

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Research Coverage Started at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a report issued on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Price Performance Shares of NYSEAMERICAN:NAVB opened at $0.09 on Monday. The company’s fifty day moving average price is $0.16 and its 200-day moving […]